BioAmber Inc fka BIOAQ

[Psychodman]

Looking over the horizon, “no or little value” as to the contracts and exclusive licensing rights. How does PWC guide the purchaser around these initial statements to the court? Hmmmm if they can’t change the amount of money currently involved in the situation to pay to shareholders without violating terms of the CCAA, what will happen?
I’m thinking a swap of shares into the new company, that’s preferred (protected) for the shareholders shares in the swap. This would be viable. The only question, will it be in an IPO?
If so what would the time limit be and what would be the guaranteed amount of each of our shares?

Bioaq shareholders must be protected